Literature DB >> 11205357

Age at onset in multiple sclerosis.

M Liguori1, M G Marrosu, M Pugliatti, F Giuliani, F De Robertis, E Cocco, G B Zimatore, P Livrea, M Trojano.   

Abstract

Age at onset of multiple sclerosis (MS) can vary from childhood to adult life. Many reports have been carried out over the years concerning the role of age at onset in determining the disease outcome. In a sporadic MS population of 1463 patients with homogeneous clinical and demographic features, derived from three Italian neurological centres (Bari, Cagliari and Sassari), we analysed the relative weights of current age and age at onset on disease severity according to the expanded disability status scale (EDSS) score, by fixing the disease duration. The results of present study demonstrate that clinical disability in MS is influenced by the patient's age (p < 0.01) and not by the age at onset. Therefore, these data do not confirm the hypothesis that an early age at onset should be considered a favourable prognostic factor of the disease outcome.

Entities:  

Mesh:

Year:  2000        PMID: 11205357     DOI: 10.1007/s100720070020

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 2.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 3.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.

Authors:  Hasan Simsek; Hikmet Geckin; Nilay Padir Sensoz; Edward O List; Ahmet Arman
Journal:  J Mol Neurosci       Date:  2018-11-16       Impact factor: 3.444

Review 5.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

6.  Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis.

Authors:  Sharadvi Thati; Christopher Kuehl; Brittany Hartwell; Joshua Sestak; Teruna Siahaan; M Laird Forrest; Cory Berkland
Journal:  J Pharm Sci       Date:  2014-12-01       Impact factor: 3.534

7.  Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis.

Authors:  Cory Teuscher; Janice Y Bunn; Parley D Fillmore; Russell J Butterfield; James F Zachary; Elizabeth P Blankenhorn
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 8.  Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review.

Authors:  Archana A Gupta; Di Ding; Richard K Lee; Robert B Levy; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

9.  Clinical characteristics of patients with late-onset multiple sclerosis.

Authors:  Bernhard Kis; Bastian Rumberg; Peter Berlit
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

10.  Prevalence of sea, seb, sec, sed, and tsst-1 genes of Staphylococcus aureus in nasal carriage and their association with multiple sclerosis.

Authors:  Zahra Pakbaz; Mohammad Ali Sahraian; Samira Sabzi; Mahmood Mahmoodi; Mohammad Reza Pourmand
Journal:  Germs       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.